Following the publication of the proposed
Biotech Act I Regulation, the European Commission has launched a consultation process for the future
Biotech Act II, which will focus on industrial policy and on building a broad, forward-looking biotechnology ecosystem.
In this session, organised by AseBio, we will examine the opportunities presented by
Biotech Act II to advance biomanufacturing and biotechnology innovation in Europe, while also addressing the regulatory, financing, and scale-up challenges facing the sector.
Estado ponentes: Moderador: Ion Arocena, General Director of AseBio
Miguel Ángel Pavón, Directorate-General for Industrial Strategy and Small and Medium-sized Enterprises (SMEs), Ministry of Industry and Turism – mandada invitación
- Mrs Kristin Schreiber, Director Chemicals, Bioeconomy and Retail, DG GROW.F, European Commission – mandada invitación
- Joerg Lindemann - MD / Site Manager WACKER
- Ana Maria Bravo-Angel, Director of Public Affairs at IFF - mandada invitación
